Smith, C., Dunbar, P., Mirza, F., Palmowski, M., Shepherd, D., Gilbert, S., . . . Cerundolo, V. (2005). Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিSmith, C., et al. Recombinant Modified Vaccinia Ankara Primes Functionally Activated CTL Specific for a Melanoma Tumor Antigen Epitope in Melanoma Patients with a High Risk of Disease Recurrence. 2005.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিSmith, C., et al. Recombinant Modified Vaccinia Ankara Primes Functionally Activated CTL Specific for a Melanoma Tumor Antigen Epitope in Melanoma Patients with a High Risk of Disease Recurrence. 2005.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.